A healthcare AI startup has introduced software that will let drugmakers market their wares directly to individual consumers without uncovering anyone’s actual identity.

The COVID-driven push to get people working from home en masse is giving AI a chance to rise above its own hype.

“The fusion of AI and healthcare is one of the most lucrative opportunities I’ve come across in my entire career,” writes the founding partner and CEO of an investment research firm.

The lab’s leaders are pledging to support innovators in various industries—including healthcare—who will have a hand in the rise of 5G technology.

The research and advisory firm says these are the areas likely to yield the biggest bang for the AI buck when it comes to making better decisions on how to deal with the pandemic.

Coviant Software is announcing it has become the first and only supplier of managed file transfer (MFT) software to fully support Google Cloud’s newly opened healthcare API for data exchange.

A company offering healthcare and wellness services to its clients’ employees is partnering with a neighboring company specialized in predictive data analytics to blunt the impact of COVID-19 on those same employees.

Several healthcare AI companies rank among the “top 25 machine learning startups to watch in 2020” in the view of a senior contributor at Forbes.com.

Sometimes there’s real progress behind the slick pitch.

An AI-championing health-tech company whose name sounds like that of a consumer group has announced a formal partnership with the Big Tech corporation behind the AI-pioneering Watson technology.

Stopping scams before they’re perpetrated, cutting illicit payments and reducing hours spent by staff on such cases are three of the top benefits administrators believe artificial intelligence could deliver to their operations.